Vienna, Austria

Sarah Spitz

This inventor holds 1 USPTO granted patent. Top assignee: Technische UNIVERSITÄT Wien. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sarah Spitz - Innovator in Microfluidic Technology

Introduction

Sarah Spitz is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of microfluidics, particularly in the cultivation of cells for generating brain organoids. Her innovative work has the potential to advance research in neuroscience and regenerative medicine.

Latest Patents

Sarah Spitz holds a patent for a microfluidic device designed for cultivating cells. This device features at least two fluid channels positioned opposite each other, with a main chamber located between them. The main chamber includes at least one sealable access opening, and each fluid channel is fluidly connected to the main chamber at multiple points of contact. A slotted structure at each point of contact separates the main chamber from the respective fluid channel, allowing for liquid permeability.

Career Highlights

Sarah is affiliated with the Technische Universität Wien, where she conducts her research and development in microfluidic technologies. Her work has garnered attention for its innovative approach to cell cultivation and its implications for brain organoid generation.

Collaborations

Sarah has collaborated with notable colleagues, including Peter Ertl and Jens Schwamborn, who share her passion for advancing scientific knowledge in their respective fields.

Conclusion

Sarah Spitz is a trailblazer in the realm of microfluidic devices, with her patent reflecting her commitment to innovation in cell cultivation. Her contributions are paving the way for future advancements in neuroscience and regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…